Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact,...
0 Comments 0 Shares
Clicky